Recovery after plastic surgery is not simply about waiting for swelling to disappear. The body must control inflammation, deliver oxygen to healing tissue, build new blood vessels, and protect the surgical area from complications.

Because oxygen is essential to these processes, some surgeons and patients have become interested in hyperbaric oxygen therapy. HBOT may have a role in selected recovery plans, particularly when tissue circulation is threatened. However, its value depends on the procedure, the patient’s health, and the reason it is being recommended.

What Is Hyperbaric Oxygen Therapy?

HBOT takes place inside a pressurized medical chamber. While pressure is increased, the patient breathes oxygen according to a prescribed protocol.

This raises dissolved oxygen levels in the bloodstream and may support oxygen delivery to tissue where circulation is limited. HBOT also influences swelling, inflammation, blood-vessel formation, and cellular responses involved in wound repair.

It does not physically repair an incision, replace good surgical technique, or correct a complication that requires another procedure.

Routine Recovery and Threatened Tissue Are Different Situations

It is important to separate two uses that are often blended together online.

The first is routine recovery after an uncomplicated elective procedure. HBOT is sometimes promoted in this setting for swelling, bruising, or faster recovery. Evidence supporting routine use remains limited.

The second involves tissue that appears threatened because its blood supply is inadequate. Examples may include selected compromised skin flaps, grafts, or areas of postoperative ischemia. These are time-sensitive medical situations requiring immediate evaluation by the operating surgeon.

HBOT may be considered as an adjunct when a surgeon believes tissue is at risk, but it cannot replace surgical examination, wound care, antibiotics when indicated, or correction of a mechanical problem affecting blood flow.

What Does the Plastic-Surgery Research Show?

A 2024 evidence review evaluated 17 human studies involving 766 participants across aesthetic and surgical applications. Every included study was judged to have a high risk of bias, meaning the overall evidence was not strong enough to support broad promises.

Some findings were encouraging. One observational study included in the review reported fewer complications when HBOT was provided before abdominoplasty. A hair-transplant study reported less early shedding, although the final hair outcome was not significantly different. The authors concluded that better randomized trials and longer follow-up are needed. Read the full evidence review on PubMed.

Published case series have also described HBOT in plastic and reconstructive surgery, including its use around compromised tissue. These reports can help physicians identify areas for further study, but they cannot tell us how every surgical patient will respond. Review the plastic-surgery case series on PubMed.

Research involving threatened mastectomy skin flaps has reported possible tissue-sparing benefits when HBOT is started promptly. However, these findings come largely from retrospective studies rather than large randomized trials. See the mastectomy-flap study on PubMed.

When Might a Conversation About HBOT Be Reasonable?

A surgeon and hyperbaric physician may consider HBOT when there is concern about:

• A compromised graft or surgical flap
• Reduced blood flow to healing tissue
• A wound that is not progressing as expected
• Significant swelling affecting tissue oxygenation
• A patient with healing risks that require coordinated management

Some patients also explore preoperative treatment. That approach remains procedure-specific and off-label in routine aesthetic care. More treatment is not automatically better, and a protocol should not be copied from another patient.

Warning Signs Require the Surgeon: Not a Wellness Appointment

Increasing pain, spreading redness, fever, drainage, wound separation, shortness of breath, asymmetric swelling, or a change in tissue color should be reported promptly to the surgical team.

HBOT should never delay emergency evaluation. Darkening skin, unusual coolness, blistering, or rapidly changing discoloration may indicate impaired circulation and requires urgent medical attention.

Planning Treatment Safely

The surgeon and hyperbaric clinician should communicate directly whenever possible. They should agree on the treatment goal, timing, pressure, number of sessions, and signs that would require the plan to change.

Patients also need screening for ear and sinus problems, lung disease, medications, implanted devices, glucose control, and other factors that can affect pressure treatment.

The Bottom Line

HBOT has a scientifically reasonable role in oxygen delivery and tissue repair, and it may be valuable in selected plastic-surgery complications. Evidence for using it routinely after every cosmetic procedure is much less certain.

The most responsible approach is individualized and collaborative: begin with the surgeon’s assessment, identify the specific recovery problem, and use HBOT only when the potential benefit justifies the treatment.

CTA

Planning a procedure or concerned about postoperative healing? Talk with RX-O2 about a coordinated HBOT consultation. Whenever possible, our team will work with your surgeon so that hyperbaric care supports—not disrupts—your surgical plan.

SOURCES

• The Role, Safety, and Efficacy of HBOT in Aesthetic Practice
• Hyperbaric Oxygen Therapy in Plastic Surgery Practice
• HBOT for Mastectomy Flap Ischemia
• HBOT and Ischemic Nipple-Sparing Mastectomy Flaps

DISCLAIMER

Information on this website is provided for educational purposes only. It is not intended as a substitute for the diagnosis, treatment, and advice of a qualified licensed professional. This website offers general information and in no way should anyone consider that this website represents the practice of medicine. This website assumes no responsibility for how this information is used. Also note that this website frequently updates its contents, due to a variety of reasons.

No statements or implied treatments on this website have been evaluated or approved by the FDA. It is important that you do not reduce, change, or discontinue any medication or treatment without first consulting your doctor. Please consult your doctor before beginning any new program of treatment.

A Parkinson’s disease diagnosis can change nearly every part of daily life. Tremor and stiffness may be the most visible symptoms, but many patients also experience poor sleep, fatigue, mood changes, and difficulty thinking clearly.

Medication, exercise, physical therapy, occupational therapy, and speech therapy remain central to Parkinson’s care. At the same time, researchers are investigating whether hyperbaric oxygen therapy, or HBOT, could become a useful supportive therapy for selected patients.

The early findings are encouraging enough to study further, but they do not show that HBOT cures Parkinson’s disease or replaces established medical treatment.

What Is Hyperbaric Oxygen Therapy?

During HBOT, a patient breathes oxygen inside a chamber where the atmospheric pressure is increased. Under pressure, the lungs can take in considerably more oxygen than they can under normal conditions.

This temporarily increases the amount of oxygen carried in the blood plasma. Oxygen can then reach tissues affected by reduced circulation, inflammation, or metabolic stress.

Researchers have proposed several reasons HBOT might be relevant to neurologic conditions. These include its possible effects on:

• Tissue oxygen availability
• Inflammatory signaling
• Oxidative stress regulation
• Mitochondrial activity
• Blood-vessel growth and circulation
• The brain’s ability to adapt after injury

These mechanisms are biologically interesting, but a plausible mechanism is not the same as proven clinical benefit.

What Did the Recent Parkinson’s Research Find?

A systematic review and meta-analysis published in 2025 combined 13 studies involving 958 participants with Parkinson’s disease. The researchers reported improvements in measures of motor function, cognition, sleep quality, and daytime sleepiness among patients receiving HBOT alongside conventional care.

The reported motor improvement included a modest change in the motor section of the Unified Parkinson’s Disease Rating Scale. The analysis also found favorable results on commonly used cognitive and sleep questionnaires. Read the Parkinson’s meta-analysis on PubMed.

These results are promising, particularly because sleep and cognitive symptoms can have a substantial effect on quality of life. However, they require careful interpretation.

The studies used different treatment protocols and were not all conducted under the same research conditions. A pooled analysis can identify a signal worth investigating, but it cannot establish that HBOT slows the underlying disease or produces the same response in every patient.

An earlier scientific review noted that much of the foundational Parkinson’s research involved laboratory and animal models. It called for stronger human studies to determine whether proposed neuroprotective effects translate into meaningful clinical outcomes. Review the earlier evidence on PubMed.

Is HBOT an Established Treatment for Parkinson’s Disease?

No. HBOT for Parkinson’s disease remains an off-label, investigational application.

That distinction matters. It means research is underway, but the evidence is not strong enough to treat HBOT as a standard Parkinson’s therapy. It should never be presented as a substitute for medication, neurologic care, rehabilitation, exercise, or other recommended treatment.

For an appropriate patient, a physician might consider HBOT as one part of a broader supportive plan. The goals should be clearly defined and measurable, for example, monitoring walking, sleep, fatigue, or cognitive function rather than relying on vague claims about “healing the brain.”

What Should Patients Consider?

HBOT requires medical screening because pressure changes and concentrated oxygen are not appropriate for everyone. A qualified clinician should review:

• Current medications and supplements
• Lung conditions or a history of collapsed lung
• Ear or sinus pressure problems
• Seizure history
• Recent surgery or implanted medical devices
• Blood-sugar management
• Claustrophobia or anxiety inside enclosed spaces

Common side effects can include temporary ear pressure, sinus discomfort, fatigue, and temporary vision changes. More serious complications are uncommon but possible, which is why medical supervision and appropriate equipment are essential. Review published HBOT side-effect information on PubMed.

A Balanced View of the Evidence

The newest Parkinson’s research gives patients and physicians a legitimate reason to remain interested in HBOT. The findings suggest possible benefits involving motor symptoms, cognition, and sleep, but the evidence does not yet prove disease modification.

Future studies should use standardized protocols, credible comparison groups, longer follow-up periods, and clearly defined patient populations. Until then, HBOT should be discussed honestly: promising, medically interesting, and still investigational for Parkinson’s disease.

CTA

If you are living with Parkinson’s disease and would like to understand whether medically supervised HBOT may fit into your broader care plan, contact RX-O2 for a patient consultation. We encourage coordination with your neurologist and existing rehabilitation team.

SOURCES

• Hyperbaric Oxygen Therapy Improves Motor Symptoms, Sleep, and Cognitive Dysfunctions in Parkinson’s Disease
• Hyperbaric Oxygen Therapy as a New Treatment Approach for Parkinson’s Disease
• Hyperbaric Oxygen Therapy: Cellular Mechanisms and Clinical Applications
• Hyperbaric Oxygen Therapy: Side Effects Defined and Quantified

DISCLAIMER

Information on this website is provided for educational purposes only. It is not intended as a substitute for the diagnosis, treatment, and advice of a qualified licensed professional. This website offers general information and in no way should anyone consider that this website represents the practice of medicine. This website assumes no responsibility for how this information is used. Also note that this website frequently updates its contents, due to a variety of reasons.

No statements or implied treatments on this website have been evaluated or approved by the FDA. It is important that you do not reduce, change, or discontinue any medication or treatment without first consulting your doctor. Please consult your doctor before beginning any new program of treatment.

For many people, Lyme disease does not end when antibiotic treatment is completed. Fatigue, muscle and joint pain, headaches, disrupted sleep, and difficulty concentrating may continue to affect work, relationships, exercise, and everyday life.

These symptoms are real, even when routine testing does not provide a simple explanation.

Researchers often use the term post-treatment Lyme disease syndrome, or PTLDS, when certain symptoms continue for at least six months after a person has completed recommended antibiotic treatment. Scientists are still studying why this happens and why some people recover quickly while others experience persistent symptoms.

For patients searching for additional ways to support recovery, hyperbaric oxygen therapy—or HBOT—may come up in conversation. Although HBOT is not an FDA-cleared treatment for Lyme disease or PTLDS, early research and limited clinical reports have created interest in its potential role as an adjunctive therapy.

Understanding Persistent Symptoms After Lyme Disease

Lyme disease is caused by bacteria from the Borrelia group and is most commonly transmitted through the bite of an infected tick. When diagnosed early, Lyme disease is generally treated with antibiotics.

Most patients improve after treatment. However, a subset of patients continues to experience symptoms such as:

• Persistent fatigue
• Muscle or joint discomfort
• Problems with memory or concentration
• Headaches
• Changes in sleep
• Reduced exercise tolerance
• Numbness, tingling, or other neurologic symptoms
• Difficulty returning to normal daily activities

A review published in Frontiers in Medicine described fatigue, cognitive difficulties, and musculoskeletal pain as common features reported by patients with PTLDS. The authors also emphasized that the biological processes contributing to these symptoms are not yet fully understood. Read the published review.

Potential explanations being investigated include changes in immune activity, persistent inflammation, tissue injury, altered neurologic function, and other effects that may remain after the initial infection has been treated. Different patients may have different factors contributing to their symptoms, which is one reason a thorough medical evaluation remains important.

What Is Hyperbaric Oxygen Therapy?

Hyperbaric oxygen therapy involves breathing increased concentrations of oxygen while inside a chamber pressurized above normal atmospheric pressure.

Under pressure, more oxygen can dissolve into the plasma and other body fluids. This allows oxygen to reach tissues through pathways that do not depend entirely on red blood cells. The combination of oxygen and pressure can also influence several biological processes involved in recovery.

Research suggests that HBOT may affect:

• Tissue oxygenation
• Inflammatory signaling
• Blood-vessel development
• Cellular energy production
• Immune activity
• The body’s repair responses

These effects are not specific to Lyme disease. They are part of the broader physiology researchers study when evaluating HBOT for wounds, neurologic injuries, inflammatory conditions, and other medical concerns. A widely cited scientific review by Stephen Thom, MD, PhD, discusses the mechanisms through which hyperbaric oxygen may influence inflammation and tissue repair. Review the published article.

What Does the Lyme Disease Research Show?

At this time, the evidence for using HBOT in patients with Lyme disease is limited.

A 2014 publication described a patient with persistent Lyme-related symptoms who experienced improvement after completing a course of HBOT. The authors called HBOT an adjunctive treatment, meaning it was used in addition to other medical care rather than as a replacement. They also acknowledged that published information about its effectiveness remained limited. Read the case report.

A case report can help identify an area worth studying, but it cannot establish that a treatment will work for most patients. It does not include a control group, and improvement in one person may not predict what another patient will experience.

An earlier review of Lyme borreliosis treatment options also noted interest in HBOT while emphasizing that controlled clinical trials had not yet been completed. Read the treatment review.

This distinction matters. There is a medical basis for continued research, but there is not currently enough evidence to say that HBOT cures Lyme disease, eliminates persistent infection, or produces predictable results for every patient.

What Might HBOT Be Used to Support?

When HBOT is considered for someone with a history of Lyme disease, the goal should be clearly defined.

Rather than promising to “kill Lyme,” a responsible treatment discussion may focus on whether HBOT could support concerns such as:

• Persistent fatigue
• Cognitive complaints or “brain fog”
• Chronic pain
• Reduced physical function
• Slow recovery after illness
• Inflammatory or neurologic symptoms

Even then, outcomes cannot be guaranteed. Symptoms associated with PTLDS can overlap with thyroid disorders, anemia, autoimmune conditions, sleep disorders, medication effects, nutritional deficiencies, other infections, and neurologic or cardiovascular problems.

HBOT should not replace an appropriate evaluation for these possibilities.

HBOT Is an Adjunct: Not a Replacement for Lyme Treatment

Hyperbaric oxygen therapy is not a substitute for antibiotics when antibiotics are medically indicated. It should also never be used as a reason to delay evaluation of new or worsening symptoms.

Patients considering HBOT should involve the healthcare professionals managing their Lyme disease or persistent symptoms. Coordination becomes especially important when a patient has heart, lung, ear, neurologic, blood-sugar, or medication-related concerns.

At RX-O2, a consultation is used to review a patient’s history, current symptoms, prior treatment, medications, possible contraindications, and goals. This helps determine whether HBOT may be reasonable as part of a broader care plan.

Safety Matters

HBOT is a medical treatment involving increased pressure and oxygen exposure. Temporary ear or sinus pressure is among the more common side effects. Other potential risks include temporary vision changes, blood-sugar changes, confinement anxiety, pulmonary effects, and, rarely, oxygen-related seizures.

A published review of HBOT side effects emphasizes the importance of proper screening, trained personnel, appropriate treatment protocols, and informed consent. Review the HBOT safety article.

Patients should look for a facility that provides:

• Medical screening before treatment
• FDA-cleared hard-shell hyperbaric chambers
• Trained and certified hyperbaric personnel
• Continuous patient supervision
• Written safety and emergency procedures
• Individualized pressure and oxygen protocols
• Communication with the patient throughout treatment

More pressure and more oxygen do not automatically mean better results. The safest and most appropriate protocol depends on the individual patient.

A Thoughtful Path Forward

Living with persistent symptoms after Lyme disease can be frustrating, particularly when the symptoms are difficult to measure or explain. Patients deserve to be taken seriously while also receiving honest information about what is known—and what remains uncertain.

HBOT has biological effects that may be relevant to inflammation, tissue oxygenation, and recovery. However, Lyme-specific research currently consists largely of limited clinical observations and case-level evidence. Larger, controlled studies are still needed.

For the right patient, HBOT may be considered as one part of a coordinated recovery plan. The decision should begin with careful screening, realistic goals, and a discussion of the potential benefits, limitations, and risks.

Could HBOT Be Appropriate for You?

If you are living with persistent symptoms following Lyme disease treatment, RX-O2 can review your medical history, current concerns, and recovery goals. A consultation does not guarantee that HBOT will be recommended, but it can help you make a more informed decision.

Schedule an HBOT consultation with RX-O2

Sources

• Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease
• Hyperbaric Oxygen Therapy as an Adjunctive Treatment for Chronic Lyme Disease: Case Report
• Review of Treatment Options for Lyme Borreliosis
• Hyperbaric Oxygen: Its Mechanisms and Efficacy
• Hyperbaric Oxygen Therapy: Side Effects Defined and Quantified

Information on this website is provided for educational purposes only. It is not intended as a substitute for the diagnosis, treatment, and advice of a qualified licensed professional. This website offers general information and in no way should anyone consider that this website represents the practice of medicine. This website assumes no responsibility for how this information is used. Also note that this website frequently updates its contents, due to a variety of reasons.

No statements or implied treatments on this website have been evaluated or approved by the FDA. It is important that you do not reduce, change, or discontinue any medication or treatment without first consulting your doctor. Please consult your doctor before beginning any new program of treatment.